Laxatives are generally quite safe when taken at the recommended dosage. However, they can cause side effects and long-term use and overuse can lead to problems.

Mounjaro (tirzepatide) is a prescription drug for adults and certain children with type 2 diabetes. One of the more common side effects of Mounjaro is constipation. In clinical studies, constipation ...

If you feel a lift after exercise, you're in good company. Movement can boost mood, and according to the results of a new study, it can also help relieve symptoms of depression. As part of a review of ...

Key insights: Refractory constipation is uncommon, and clinicians should first rule out treatable secondary causes, such as medication side effects, neurologic conditions, or defecatory disorders.

According to statistics, around one in seven UK adults struggles with constipation. Beyond causing discomfort, constipation can be painful and, if left untreated, can significantly affect quality of ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

Although the condition is widespread and serious, there are still no approved medications that can actively restore kidney function. A team led by Professor Takaaki Abe at the Tohoku University ...

What Is Crohn’s Constipation? You likely have constipation if it's hard for you to poop and you're having fewer bowel movements than you normally do. The same is true whether or not you have Crohn’s ...

aDepartment of Paediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands bAmsterdam Gastroenterology Endocrinology Metabolism Research ...

I usually open this newsletter with a personal story — but this week’s topic is constipation, so I’ll spare you. A lot of us fret about our regularity. But constipation is defined as fewer than three ...

FDA approves first irritable bowel syndrome with constipation (IBS-C) treatment, linaclotide (Linzess), for children aged 7 years and older based on pediatric and adult trial data. Compared with ...